Literature DB >> 1716291

T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.

E J Wiertz1, J A van Gaans-van den Brink, G M Schreuder, A A Termijtelen, P Hoogerhout, J T Poolman.   

Abstract

No vaccine is yet available against serogroup B meningococci, which are a common cause of bacterial meningitis. Some outer membrane proteins (OMP), LPS, and capsular polysaccharides have been identified as protective Ag. The amino acid sequence of the protective B cell epitopes present within the class 1 OMP has been described recently. Synthetic peptides containing OMP B cell epitopes as well as capsular polysaccharides or LPS protective B cell epitopes have to be presented to the immune system in association with T cell epitopes to achieve an optimal Ir. The use of homologous, i.e., meningococcal, T cell epitopes has many advantages. We therefore investigated recognition sites for human T cells within the meningococcal class 1 OMP. We have synthesized 16 class 1 OMP-derived peptides encompassing predicted T cell epitopes. Peptides corresponding to both surface loops and trans-membrane regions (some of which occur as amphipathic beta-sheets) of the class 1 OMP were found to be recognized by T cells. In addition, 10 of 11 peptides containing predicted amphipathic alpha-helices and four of five peptides containing T cell epitope motifs according to Rothbard and Taylor (Rothbard, J. B., and W. R. Taylor. 1988. EMBO J 7:93) were recognized by lymphocytes from one or more volunteers. Some of the T and B cell epitopes were shown to map to identical regions of the protein. At least six of the peptides that were found to contain T cell epitopes show homology to constant regions of the meningococcal class 3 OMP and the gonococcal porins PIA and PIB. Peptide-specific T cell lines and T cell clones were established to investigate peptide recognition in more detail. The use of a panel of HLA-typed APC revealed clear HLA-DR restriction patterns. It seems possible now to develop a (semi-) synthetic meningococcal vaccine with a limited number of constant T cell epitopes that cover all HLA-DR locus products.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716291

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Cellular Immune Responses in Humans Induced by Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Given Separately and in Combination.

Authors:  Fredrik Oftung; Gro Ellen Korsvold; Audun Aase; Lisbeth M Næss
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine.

Authors:  F Oftung; L M Naess; L M Wetzler; G E Korsvold; A Aase; E A Høiby; R Dalseg; J Holst; T E Michaelsen; B Haneberg
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

3.  Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.

Authors:  L M Naess; F Oftung; A Aase; L M Wetzler; R Sandin; T E Michaelsen
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Vaccination and the population structure of antigenically diverse pathogens that exchange genetic material.

Authors:  S Gupta; N M Ferguson; R M Anderson
Journal:  Proc Biol Sci       Date:  1997-10-22       Impact factor: 5.349

5.  Identification and characterization of TspA, a major CD4(+) T-cell- and B-cell-stimulating Neisseria-specific antigen.

Authors:  G Kizil; I Todd; M Atta; S P Borriello; K Ait-Tahar; D A Ala'Aldeen
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

6.  T-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Opc, and PorA proteins.

Authors:  E J Wiertz; A Delvig; E M Donders; H F Brugghe; L M van Unen; H A Timmermans; M Achtman; P Hoogerhout; J T Poolman
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

7.  Cellular immune responses to Neisseria meningitidis in children.

Authors:  A J Pollard; R Galassini; E M Rouppe van der Voort; M Hibberd; R Booy; P Langford; S Nadel; C Ison; J S Kroll; J Poolman; M Levin
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

8.  Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.

Authors:  Manish Sadarangani; J Claire Hoe; Martin J Callaghan; Claire Jones; Hannah Chan; Katherine Makepeace; Hélène Daniels-Treffandier; Mary E Deadman; Christopher Bayliss; Ian Feavers; Peter van der Ley; Andrew J Pollard
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis.

Authors:  E J Wiertz; J A van Gaans-van den Brink; H Gausepohl; A Prochnicka-Chalufour; P Hoogerhout; J T Poolman
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.

Authors:  Claire Jones; Manish Sadarangani; Susan Lewis; Isabelle Payne; Muhammad Saleem; Jeremy P Derrick; Andrew J Pollard
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.